Related Experiment Video
Updated: Oct 2, 2025

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling
Published on: June 23, 2022
Misidentification of the SARS-CoV-2 Mu variant using commercial mutation screening assays
Izaskun Alejo-Cancho1,2, Ana Gual-de-Torrella3,4, Mikel Gallego5,4
1Microbiology Department, Hospital Universitario Galdakao-Usansolo, Osakidetza Basque Health Service, Galdakao, Spain. i.alejo.cancho@gmail.com.
Abstract:
Detection of mutations by multiplex real-time RT-PCR is a widely used method for the screening of SARS-CoV-2 variants, but this method has several limitations. We describe three cases in which a Mu strain containing the mutation K417N was initially misclassified as the Beta variant. We recommend the detection of P681H to distinguish between these two variants. Our experience highlights the importance of keeping track of new variants and mutations in order to adapt the current workflows.
More Related Videos
10:41Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
Published on: March 29, 2017
10:57Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay
Published on: August 14, 2018